08:00 , Mar 5, 2015 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: S. aureus M42 family glutamyl aminopeptidase (PepA1)

Infectious disease INDICATION: Bacterial infection Cell culture studies suggest a cyclic heptapseudopeptide derived from the Staphylococcus aureus toxin PepA1 could help treat both Gram-negative and Gram-positive bacterial infections without the hematological toxicity of the parent...